An at-home pill against coronavirus halves the chance that people newly diagnosed with COVID-19 will land in the hospital or die, early results released by the drug’s developer ...

New research reveals a potentially effective COVID-19 pill is in the works. Here’s what infectious disease experts want you ...

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations of Paxlovid, currently the most prescribed oral treatment. As with its ...

The antiviral drug ensitrelvir prevents infection in household contacts of COVID-19 patients when given within 72 hours after symptom onset in the index patient, according to a Phase III randomized ...

An illustration shows a molecule nestled inside a large lumpy green mass. According to researchers' predictions, the antiviral candidate, venetoclax (red and purple), could limit SARS-CoV-2's ability ...

Glenmark Pharmaceuticals on Saturday said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the ...

Ensitrelvir represents a significant advancement in the treatment of COVID-19, setting the stage for enhanced defenses ...

Many of the most devastating infectious diseases are caused by RNA viruses, and Model Medicines is working on one compound to kill them all. The AI drug discoverer’s oral small molecule was able to ...

No antivirals are approved as postexposure prophylaxis for household contacts of people with COVID-19. In this randomized study, 2.9% of household contacts who took ensitrelvir developed COVID within ...

The antiviral favipiravir, from the Japanese company Fujifilm, that gained fame during the COVID-19 pandemic, is being ...